Lantheus Holdings Inc. | Mid-cap | Healthcare
$79.42
-2.98%
| Lantheus Holdings Stock Comparison:
Lantheus Holdings vs ZoetisLantheus Holdings vs Haleon Plc - ADRLantheus Holdings vs Regencell BioscienceLantheus Holdings vs Elanco Animal HealthLantheus Holdings vs Alkermes plcLantheus Holdings vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 1.5B
Gross Profit 988.3M 64.43%
Operating Income 448.6M 29.24%
Net Income 312.4M 20.37%
EPS (Diluted) $4.36

Balance Sheet Metrics

Total Assets 2.0B
Total Liabilities 892.3M
Shareholders Equity 1.1B
Debt to Equity 0.82

Cash Flow Metrics

Operating Cash Flow 463.7M
Free Cash Flow 465.1M

Revenue & Profitability Trend

Lantheus Holdings Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 1.5B 1.3B 935.1M 425.2M 339.4M
Cost of Goods Sold 545.6M 586.9M 353.4M 237.5M 200.6M
Gross Profit 988.3M 709.5M 581.7M 187.7M 138.8M
Research & Development 168.1M 77.7M 311.7M 45.0M 32.8M
Selling, General & Administrative 371.6M 267.2M 233.8M 218.8M 110.2M
Other Operating Expenses 0 0 0 0 0
Total Operating Expenses 539.7M 344.9M 545.5M 263.8M 143.0M
Operating Income 448.6M 364.6M 36.2M -76.1M -4.2M
Pre-tax Income 431.0M 410.9M 26.7M -75.0M -11.5M
Income Tax 118.5M 84.3M -1.3M -3.8M 2.0M
Net Income 312.4M 326.7M 28.1M -71.3M -13.5M
EPS (Diluted) $4.36 $4.65 $0.40 -$1.06 -$0.25

Income Statement Trend

Lantheus Holdings Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 1.3B 1.1B 677.6M 235.8M 184.2M
Non-Current Assets 653.7M 565.3M 643.6M 628.0M 685.6M
Total Assets 2.0B 1.7B 1.3B 863.8M 869.8M
Liabilities
Current Liabilities 240.5M 187.4M 247.7M 90.5M 80.5M
Non-Current Liabilities 651.8M 647.9M 626.4M 308.8M 275.1M
Total Liabilities 892.3M 835.3M 874.1M 399.3M 355.6M
Equity
Total Shareholders Equity 1.1B 815.9M 447.1M 464.4M 514.2M

Balance Sheet Composition

Lantheus Holdings Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income 312.4M 326.7M 28.1M -71.3M -13.5M
Operating Cash Flow 463.7M 292.2M 216.0M 40.1M 6.0M
Investing Activities
Capital Expenditures - - - - -
Investing Cash Flow -146.4M 52.5M -258.2M 15.8M 7.6M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -121.8M -16.9M 304.2M -44.6M -21.9M
Free Cash Flow 465.1M 258.7M 263.4M 41.8M 3.9M

Cash Flow Trend

Lantheus Holdings Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 23.07
Forward P/E 11.68
Price to Book 4.81
Price to Sales 3.64
PEG Ratio 11.68

Profitability Ratios

Profit Margin 16.55%
Operating Margin 27.38%
Return on Equity 24.11%
Return on Assets 14.39%

Financial Health

Current Ratio 5.74
Debt to Equity 52.78
Beta 0.10

Per Share Data

EPS (TTM) $3.51
Book Value per Share $16.84
Revenue per Share $22.21

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
lnth 5.6B 23.07 4.81 24.11% 16.55% 52.78
Zoetis 70.3B 28.34 15.12 52.09% 27.12% 145.63
Haleon Plc - ADR 47.2B 25.01 5.88 8.95% 12.84% 63.41
Regencell Bioscience 18.5B - 1,394.12 -43.18% 0.00% 1.04
Elanco Animal Health 6.6B 17.80 1.04 6.01% 8.43% 69.18
Alkermes plc 4.8B 13.93 3.19 25.71% 23.30% 4.90

Financial data is updated regularly. All figures are in the company's reporting currency.